Effects of Escherichia coli Nissle 1917 and Ciprofloxacin on small intestinal epithelial cell mRNA expression in the neonatal piglet model of human rotavirus infection

Gut Pathogens

Volumn 8, Issue 1, 2016, Pages 1-7

  Paim, Francine C ^a   Langel, Stephanie N ^a   Fischer, David D ^a   Kandasamy, Sukumar ^a   Shao, Lulu ^a,b   Alhamo, Moyasar A ^a   Huang, Huang Chi ^a   Kumar, Anand ^a,c   Rajashekara, Gireesh ^a   Saif, Linda J ^a   Vlasova, Anastasia N ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c LOS ALAMOS NATIONAL LABORATORY   (United States)

Author keywords

Antibiotic; Commensal microflora; Gnotobiotic piglets; Human rotavirus; Intestinal epithelial cell specific genes; Probiotic

Indexed keywords

EID: 85003856413     PISSN: None     EISSN: 17574749     Source Type: Journal    
DOI: 10.1186/s13099-016-0148-7     Document Type: Article

References (42)

1. Lundgren O, Svensson L. Pathogenesis of rotavirus diarrhea. Microbes Infect. 2001;3:1145-56.
2. World Health Organization. Global and national estimates of deaths under age five attributable to rotavirus infection: 2004. 2006. http://www.who.int/immunization_monitoring/burden/rotavirus_estimates/en/. Accessed 10 Oct 2016.
3. Saif LJ, Ward LA, Yuan L, Rosen BI, To TL. The gnotobiotic piglet as a model for studies of disease pathogenesis and immunity to human rotaviruses. Arch Virol Suppl. 1996;12:153-61.
4. Verikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodrigez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354:23-33.
5. Gray J. Rotavirus vaccines: safety, efficacy and public health impact. J Intern Med. 2011;270:206-14.
6. Simpson E, Wittet S, Bonilla J, Gamazina K, Cooley L, Winkler JL. Use of formative research in developing a knowledge translation approach to rotavirus vaccine introduction in developing countries. BMC Public Health. 2007;7:281.
7. Sullivan A, Nord CE. Probiotics and gastrointestinal diseases. J Intern Med. 2005;257:78-92.
8. Martín R, Miquel S, Ulmer J, Kechaou N, Langella P, Bermúdez-Humarán LG. Role of commensal and probiotic bacteria in human health: a focus on inflammatory bowel disease. Microb Cell Fact. 2013;12:71.
9. Behnsen J, Deriu E, Sassone-Corsi M, Raffatellu M. Probiotics: properties, examples, and specific applications. Cold Spring Harb Perspect Med. 2013;3:a010074.
10. Kandasamy S, Vlasova AN, Fischer D, Kumar A, Chatta KS, Rauf A, Shao L, Langel SN, Rajashekara G, Saif LJ. Differential effects of Escherichia coli Nissle and lactobacillus rhamnosus strain gg on human rotavirus binding, infection, and B cell immunity. J Immunol. 2016;196:1780-9.
11. Vlasova AN, Shao L, Kandasamy S, Fischer DD, Rauf A, Langel SN, Chattha KS, Kumar A, Huang HC, Rajashekara G, Saif LJ. Escherichia coli Nissle 1917 protects gnotobiotic piglets against human rotavirus by modulating pDC and NK-cell responses. Eur J Immunol. 2016;46:2426-37.
12. Peterson LW, Artis D. Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat Rev Immunol. 2014;14:141-53.
13. Laycok G, Sait L, Inman C, Lewis M, Smidt H, van Diemen P, Jorgensen F, Stevens M. A defined intestinal colonization microbiota for gnotobiotic pigs. Vet Immunol Immunopathol. 2012;149:216-24.
14. Butler JE, Weber P, Sinkora M, Baker D, Schoenherr A, Mayer B, Francis D. Antibody repertoire development in fetal and neonatal piglets. VIII. Colonization is required for newborn piglets to make serum antibodies to T-dependent and type 2 T-independent antigens. J Immunol. 2002;169:6822-30.
15. Butler JE, Francis DH, Freeling J, Weber P, Krieg AM. Antibody repertoire development in fetal and neonatal piglets. IX. Three pathogen-associated molecular patterns act synergistically to allow germfree piglets to respond to type 2 thymus-independent and thymus-dependent antigens. J Immunol. 2005;175:6772-85.
16. Butler JE, Sun J, Weber P, Navarro P, Francis D. Antibody repertoire development in fetal and newborn piglets, III. Colonization of the gastrointestinal tract selectively diversifies the preimmune repertoire in mucosal lymphoid tissues. Immunology. 2000;100:119-30.
17. Macpherson AJ, Harris NL. Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol. 2004;4:478-85.
18. Zaghouani H, Hoeman CM, Adkins B. Neonatal immunity: faulty T-helpers and the shortcomings of dendritic cells. Trends Immunol. 2009;30:585-91.
19. Siegrist CA, Aspinall R. B-cell responses to vaccination at the extremes of age. Nat Rev Immunol. 2009;9:185-94.
20. Meyer RC, Bohl EH, Kohler EM. Procurement and maintenance of germ-free seine for microbiological investigations. Appl Microbiol. 1964;12:295-300.
21. Yuan L, Kang SY, Ward LA, To TL, Saif LJ. Antibody-secreting cell responses and protective immunity assessed in gnotobiotic pigs inoculated orally or intramuscularly with inactivated human rotavirus. J Virol. 1998;72:330-8.
22. Pan D, Das A, Liu D, Veazey RS, Pahar B. Isolation and characterization of intestinal epithelial cells from normal and SIV-infected rhesus macaques. PLoS ONE. 2012;7:e30247.
23. Gonzalez LM, Williamson I, Piedrahita JA, Blikslager AT, Magness ST. Cell lineage identification and stem cell culture in a porcine model for the study of intestinal epithelial regeneration. PLoS ONE. 2013;8:e66465.
24. Nossol C, Diesing AK, Walk N, Faber-Zuschratter H, Harting R, Post A, Kluess J, Rothkötter J, Kahlert S. Air-liquid interface cultures enhance the oxygen supply and trigger the structural and functional differentiation of intestinal porcine epithelial cells (IPEC). Histochem Cell Biol. 2011;136:103-15.
25. Collado-Romero M, Arce C, Ramírez-Boo M, Carvajal A, Garrido JJ. Quantitative analysis of the immune response upon Salmonella typhimurium infection along the porcine intestinal gut. Vet Res. 2010;41:23.
26. Livak KJ, Schmittgen TD. Analyzing real-time PCR data by the comparative C (T) method. Nat Protoc. 2008;3:1101-8.
27. Dethlefsen L, Huse S, Sogin ML, Relman DA. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16s RRNA sequencing. PLoS Biol. 2008;6:e280.
28. Wlodarska M, Willing B, Keeney KM, Menendez A, Bergstrom KS, Gill N, Russel SL, Vallence BA, Finlay BB. Antibiotic Treatment Alters the Colonic Mucus Layer and Predisposes the Host to Exacerbated Citrobacter rodentium-induced colitis. Infect Immun. 2011;79:1536-45.
29. Wlodarska M, Finlay BB. Host immune response to antibiotic perturbation of the microbiota. Mucosal Immunol. 2010;3:100-3.
30. Boshuizen JA, Reimerink JH, Korteland-van Male AM, van Ham VJ, Koopmans MP, Büller HA, Dekker J, Einerhand AW. Changes in small intestinal homeostasis, morphology, and gene expression during rotavirus infection of infant mice. J Virol. 2003;24:13005-16.
31. Rijke RP, Hanson WR, Plaisier HM, Osborne JW. The effect of ischemic villi age on crypt cell proliferation in the small intestine: evidence for a feedback control mechanism. Gastroenterology. 1976;5:786-92.
32. Honeyman MC, Laine D, Zhan Y, Londrigan S, Kirkwood C, Harrison LC. Rotavirus infection induces transient pancreatic involution and hyperglycemia in weanling mice. PLoS ONE. 2014;9:e106560.
33. Preidis GA, Saulnier DM, Blutt SE, Mistretta TA, Riehle KP, Major AM, Venable SF, Barrish JP, Finegold MJ, Petrosino JF, Guerrant RL, Conner ME, Versalovic J. Host response to probiotics determined by nutritional status of rotavirus-infected neonatal mice. J Pediatr Gastroenterol Nutr. 2014;55:299-307.
34. Henker J, Laass MW, Blokhin BM, Maydannik VG, Bolbot YK, Elze M, Wolff C, Schreiner A, Schulze J. Probiotic Escherichia coli Nissle 1917 versus placebo for treating diarrhea of greater than 4 days duration in infants and toddlers. Pediatr Infect Dis J. 2008;27:494-9.
35. Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM, Axon AT. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet. 1999;354:635-9.
36. Schultz M. Clinical use of E. coli Nissle, in inflammatory bowel disease. Inflamm Bowel Dis. 1917;2008(7):1012-8.
37. Boudeau J, Glasser AL, Julien S, Colombel JF, Darfeuille-Michaud A. Inhibitory effect of probiotic Escherichia coli strain Nissle 1917 on adhesion to and invasion of intestinal epithelial cells by adherent-invasive E. coli strains isolated from patients with Crohn's disease. Aliment Pharmacol Ther. 2003;18:45-56.
38. Nair GB, Takeda Y. ECAB health impact of probiotics: vision and opportunities. India: Elsevier; 2012.
39. Skipper M, Lewis J. Getting to the guts of enteroendocrine differentiation. Nat Genet. 2000;1:3-4.
40. Carulli AJ, Samuelson LC, Schnell S. Unraveling intestinal stem cell behavior with models of crypt dynamics. Integr Bio (Camb). 2014;6:243-57.
41. Dubey V, Ghosh AR. Probiotics cross talk with multi cell signaling in colon carcinogenesis. J Prob Health. 2013;1:109.
42. Banasaz M, Norin E, Holma R, Midtvedt T. Increased enterocyte production in gnotobiotic rats mono-associated with Lactobacillus rhamnosus GG. Appl Environ Microbiol. 2002;68:3031-4.